Search Results
Results found for "Chris Tate"
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Welcome back GPCR fans, The pace of GPCR innovation is accelerating at a rate that can be difficult to
- š° GPCR Weekly News, May 8 to 14, 2023
Clinical Stage X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate
- VAMP2: a crucial player in the delivery of MOR to the synapse
Phosphorylation state of muopioid receptor determines the alternative recycling of receptor via Rab4
- š° GPCR Weekly News, April 10 to 16, 2023
Save the date! Join us for the upcoming Dr.
- š° GPCR Weekly News, June 26 to July 2, 2023
Let's take a quick look at the weekly Classified GPCR News from June 26th to July 2nd, 2023.
- š¤ÆMind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
GPCR Events You can begin organizing and marking a few dates in 2025 .
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
including multicellular organisms and human cells, to better mimic physiological conditions and disease states
- š° GPCR Weekly News, April 22 to 28, 2024
Please completeĀ this formĀ to take advantage of this opportunity on a first-come, first-served basis.
- š° GPCR Weekly News, April 15 to 21, 2024
Please completeĀ this formĀ to take advantage of this opportunity on a first-come, first-served basis.
- GPCR Buzz of the Week | Sep 23 - 29, 2024
Let's take your brand to the next level together!
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
This week, Terryās Corner takes you beyond curve shapes into the kinetic and mechanistic realities that
- The One Reason Why Biotech Startups Fail More Often Than They Should
It is about designing clarity early enough that chaos never takes over.
- š° GPCR Weekly News, March 13 to 19, 2023
We thrive to keep you up-to-date with everything happening in the world of GPCR.
- Chemokine receptor-targeted drug discovery: progress and challenges
Therefore, the in vivoĀ state of the receptor and its existence as homo and herero-oligomeres at the cell
- From Failed Experiments to Predictive GPCR Models
When he moved to Uppsala in the late 1990s to study engineering, it was biotechnologyāthen on the riseāthat
- āµSailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
GPCR Events You can start planning and save some dates in 2025 .
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
reality starts with hepatic metabolism , where enzymes such as cytochrome P450s Ā determine a moleculeās fate
- A2A Fluorescent Competitive Binding: Advancing NanoBRETĀ® Target Engagement for GPCR Drug Discovery
Celtarysā technology significantly reduces the time it takes to obtain fluorescent tags and test varying Berlin, Heidelberg, 2009; Vol. 193, pp 1ā24. https://doi.org/10.1007/978-3-540-89615-9_1 . (8) Yung-Chi
- š° GPCR Weekly News, May 13 to 19, 2024
Stay informed and up to date with the latest GPCR research and industry news.
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Illuminating GPCR trafficking Cell swelling enhances ligand-driven β-adrenergic signaling Roles of the gate
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
The FA values were normalized by taking the average FA value of C = 0 points as 100% and the average Netherlands: Dordrecht, 2014; pp 55ā74. https://doi.org/10.1007/978-94-007-7423-0_4 . (12)Ā Ā Ā Ā Ā Yung-Chi H.; Bates, M.; Zhuang, X.
- New role of β-arrestins in MOR signaling
With this in mind one of the proposals is to take advantage of biased agonism, i.e. when the same receptor
- The Hidden Cost of Unclear Biotech Positioning
Investor calls take too long before reaching substance.
- Early Stage Biotech Hiring: What Really Holds a Team Together When the Science Starts to Drift
Early-stage biotech rewards people who take responsibility beyond their formal scope. 4ļøā£ How they balance
- Targeting Intracellular Allosteric Sites in GPCRs
resulting change in conformation can influence the orthosteric binding pocket, potentially altering the rate
- š° GPCR Weekly News, March 27 to April 4, 2023
Hello Readersš, This week in the GPCR news we have collected the most up-to-date news for you.
- š° GPCR Weekly News, January 30 to February 5, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
HTRF Ratio = 665 nm acceptor signal/620 nm donor signal Ć 10,000; the percentage is calculated by taking HTRF Ratio = 665 nm acceptor signal/620 nm donor signal Ć 10,000; the percentage is calculated by taking
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Proceedings of the National Academy of Sciences of the United States of America, 100(19), 10782ā10787


















